BISOPROLOL FUMARATE
CONCORE
5mg Film-Coated Tablet
Indication*
HTN as substitution therapy in patients adequately controlled with the individual products given concurrently at the same doses level as in the combination, but as separate tab. HTN in patients whose BP cannot be controlled by bisoprolol or amlodipine therapy.
This is not a substitute for consulting your doctor. Seek professional advice if you are experiencing any illness or symptoms.
Directions for Use*
Patient whose BP is adequately controlled with separately administered mono-component products of the same dose as the recommended fixed dose combination 1 tab daily. Patient whose BP is inadequately controlled with bisoprolol or amlodipine alone Initially 5mg/ 5mg for the the 1st 6 week. May increase to 5 mg/ 10mg after or 10mg/5mg after 6 week, may further increase to 10mg/10mg after 6 week. Severe renal impairment (CrCI <20mL/min) Max: 10mg daily. Hepatic impairment Max: 10mg daily.
Administration*
May be taken with or without food: Take in the morning. Swallow with some liquid, do not chew.
*written indications, directions, and administration are updated as of March 05, 2024 and may not be accurate with the actual product purchased. Please read the details in the packaging.
Couldn't load pickup availability
Savings for your stock-up (Members only)
| 7 pcs (1 week) | 30 pcs (1 month) | 35 pcs | |
|---|---|---|---|
| Member total | ₱184.80 | ₱792.00 | ₱924.00 |
| Regular total | ₱231.00 | ₱990.00 | ₱1,155.00 |
| You save | ₱46.20 | ₱198.00 | ₱231.00 |